Literature DB >> 3827529

The surgical pathology of hypertrophic cardiomyopathy.

H D Tazelaar, M E Billingham.   

Abstract

The pathologic diagnosis of hypertrophic cardiomyopathy (HCM) rests on the gross cardiac morphology and the presence and extent of myofiber disarray in the interventricular septum. Little attention, however, has been focused on the features of HCM in endomyocardial biopsy or septal myomectomy specimens. We therefore examined nine right ventricular biopsy specimens and 89 myomectomy specimens from 98 patients with clinically diagnosed HCM. Myofiber disarray was present in three (33%) of the biopsy specimens and 52 (58%) of the septectomy specimens. Associated findings in both specimen types included myocyte hypertrophy and interstitial fibrosis. The myomectomy specimens also frequently contained areas of patchy fibrosis, abnormally thick coronary arteries, and a fibrous endocardial plaque. When myofiber disarray was present in myomectomy specimens, it was confined to the deepest portion in 79% of the specimens, confirming that the disarray is frequently confined to the middle transverse third of the septum. Endomyocardial biopsy specimens may be used to suggest the diagnosis of HCM; however, because of their small size and their relatively nonspecific pathologic changes, they are of limited value in making the diagnosis of HCM. Septal myomectomy specimens usually contain pathologic findings consistent with HCM. The role of the surgical pathologist in the myomectomy cases is to confirm that these changes are present and are characteristic of the disorder.

Entities:  

Mesh:

Year:  1987        PMID: 3827529

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.

Authors:  Jens Mogensen; Toru Kubo; Mauricio Duque; William Uribe; Anthony Shaw; Ross Murphy; Juan R Gimeno; Perry Elliott; William J McKenna
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations.

Authors:  Christopher J McLeod; J Martijn Bos; Jeanne L Theis; William D Edwards; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Journal:  Am Heart J       Date:  2009-10-03       Impact factor: 4.749

3.  Prognostic Significance of Plasma High-Sensitivity C-Reactive Protein in Patients With Hypertrophic Cardiomyopathy.

Authors:  Ling Zhu; Yubao Zou; Yilu Wang; Xiaoliang Luo; Kai Sun; Hu Wang; Lei Jia; Yan Liu; Juan Zou; Zuyi Yuan; Rutai Hui; Lianming Kang; Lei Song; Jizheng Wang
Journal:  J Am Heart Assoc       Date:  2017-02-02       Impact factor: 5.501

4.  Routine histopathology of septal myectomy for hypertrophic obstructive cardiomyopathy in a greek cohort.

Authors:  Nikolaos S Ioakeimidis; Antonios Pitsis; Dimitrios Ntelios; Thomas Zegkos; Timotheos Kelpis; Theodora Papamitsou; Despoina Parcharidou; Georgios Efthimiadis; Soultana Meditskou
Journal:  Histol Histopathol       Date:  2021-07-30       Impact factor: 2.303

5.  Speckle tracking echocardiography to assess regional ventricular function in patients with apical hypertrophic cardiomyopathy.

Authors:  María Cristina Saccheri; Tomás Francisco Cianciulli; Luis Alberto Morita; Ricardo José Méndez; Martín Alejandro Beck; Juan Enrique Guerra; Alberto Cozzarin; Luciana Jimena Puente; Lorena Romina Balletti; Jorge Alberto Lax
Journal:  World J Cardiol       Date:  2017-04-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.